Literature DB >> 8630416

Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.

H Poirel1, K Rack, E Delabesse, I Radford-Weiss, X Troussard, C Debert, D Leboeuf, C Bastard, F Picard, A Veil-Buzyn, G Flandrin, O Bernard, E Macintyre.   

Abstract

To determine the incidence of MLL rearrangement in acute myeloid leukemia (AML) French-American-British (FAB) type M1 and to evaluate optimal screening strategies for the characterization of such abnormalities, we analyzed specimens from 41 patients with AML by Southern blotting with two MLL genomic probes and compared the capacities of reverse transcription-polymerase chain reaction (RT-PCR) and fluorescent in situ hybridization (FISH) to identify the types of rearrangement found in AML M1 with those observed in AML M5. MLL rearrangement was found in 6 of 29 (20%) AML M1 and 6 of 10 AML M5 cases. RT-PCR characterization of 11 cases showed four MLL self-fusions, four MLL-AF6, two MLL-AF9, including a novel AF9 breakpoint, and one uncharacterized t(11:19). Only 5 of 10 MLL-rearranged cases tested demonstrated karyotypic 11q23 abnormalities. FISH analysis of nine cases with an MLL-specific yeast artificial chromosome (YAC) confirmed the cytogenetic abnormalities in two cases, clarified them in one, and did not detect six cases, including three MLL self-fusions, one case with a probable MLL-rearranged subclone not represented karyotypically, and twoMLL-AF6. A whole chromosome 11 paint detected one of these MLL-AF6, and an AF6 cosmid demonstrated that the other was probably due to insertion of a submicroscopic portion of chromosome 6, including part of AF6, into an apparently normal chromosome 11. We conclude that MLL rearrangements are common in adult AML M1, that MLL self-fusion and MLL-AF6 are the most frequent types of abnormalities, and that RT-PCR is preferable to 11q23 FISH analysis for their characterization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630416

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.

Authors:  Michaela Liedtke; Paul M Ayton; Tim C P Somervaille; Kevin S Smith; Michael L Cleary
Journal:  Blood       Date:  2010-04-15       Impact factor: 22.113

Review 2.  Childhood cancer: improved prospects for survival but is prevention possible?

Authors:  A W Craft
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

Review 3.  Cell cycle control and cancer.

Authors:  H P Wagner
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

4.  The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.

Authors:  C Caslini; A Shilatifard; L Yang; J L Hess
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Gene rearrangement: a novel mechanism for MDR-1 gene activation.

Authors:  L A Mickley; B A Spengler; T A Knutsen; J L Biedler; T Fojo
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.

Authors:  M P Strout; G Marcucci; C D Bloomfield; M A Caligiuri
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.

Authors:  J Zhou; J Wu; B Li; D Liu; J Yu; X Yan; S Zheng; J Wang; L Zhang; L Zhang; F He; Q Li; A Chen; Y Zhang; X Zhao; Y Guan; X Zhao; J Yan; J Ni; M A Nobrega; B Löwenberg; R Delwel; P J M Valk; A Kumar; L Xie; D G Tenen; G Huang; Q-F Wang
Journal:  Leukemia       Date:  2013-12-26       Impact factor: 11.528

Review 8.  Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Authors:  Ann Peters; Paul W Burridge; Marina V Pryzhkova; Michal A Levine; Tea-Soon Park; Christopher Roxbury; Xuan Yuan; Bruno Péault; Elias T Zambidis
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

9.  STAT3β is a tumor suppressor in acute myeloid leukemia.

Authors:  Petra Aigner; Tatsuaki Mizutani; Jaqueline Horvath; Thomas Eder; Stefan Heber; Karin Lind; Valentin Just; Herwig P Moll; Assa Yeroslaviz; Michael J M Fischer; Lukas Kenner; Balázs Győrffy; Heinz Sill; Florian Grebien; Richard Moriggl; Emilio Casanova; Dagmar Stoiber
Journal:  Blood Adv       Date:  2019-07-09

10.  EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia.

Authors:  C W So; C Caldas; M M Liu; S J Chen; Q H Huang; L J Gu; M H Sham; L M Wiedemann; L C Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.